Alaunos Therapeutics
TCRT
138 hedge funds and large institutions have $570M invested in Alaunos Therapeutics in 2015 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 54 increasing their positions, 43 reducing their positions, and 36 closing their positions.
26% more repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 43
12% less funds holding
Funds holding: 156 → 138 (-18)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
28% less capital invested
Capital invested by funds: $794M → $570M (-$225M)
38% less call options, than puts
Call options by funds: $19.2M | Put options by funds: $30.8M
50% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 36
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$7.26M |
| 2 |
Norges Bank
Oslo,
Norway
|
+$6.18M |
| 3 |
Zurich Cantonal Bank
Zurich,
Switzerland
|
+$5.98M |
| 4 |
MVP
Miller Value Partners
Sarasota,
Florida
|
+$5.24M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$3.36M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TP
Third Point
New York
|
-$23.4M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$18M |
| 3 |
CCS
Crosspoint Capital Strategies
Orinda,
California
|
-$6.53M |
| 4 |
YCMGA
York Capital Management Global Advisors
New York
|
-$5.14M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$3.66M |
TCRT Hedge Fund Activity: Q3 2015 in Review
138 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Alaunos Therapeutics (TCRT) for Q3 2015, worth a combined $570M — down 28% from $794M a quarter earlier.
Sellers outnumbered buyers: 36 funds closed out of TCRT and 18 opened new positions — a net loss of 18 holders — while 43 trimmed existing stakes and 54 added.
The largest buyer was Susquehanna International Group, adding an estimated $7.26M. The largest seller was Third Point, exiting entirely with an estimated $23.4M sold.
- 138 institutional investors held Alaunos Therapeutics (TCRT) as of Q3 2015, down from 156 in Q2 2015.
- Funds reported $570M of Alaunos Therapeutics stock for Q3 2015, down 28% quarter-over-quarter.
- 18 funds opened new Alaunos Therapeutics positions in Q3 2015 and 36 closed out, a net change of -18 holders.
- The largest Alaunos Therapeutics buyer in Q3 2015 was Susquehanna International Group, an estimated $7.26M added.
- The largest Alaunos Therapeutics seller in Q3 2015 was Third Point, an estimated $23.4M sold.
Based on aggregated 13F filings for Q3 2015.